The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Ubiquitin, TAK1 and IKK: is there a connection?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Extracellular inflammatory signals including lipopolysaccharide (LPS), pro-inflammatory cytokines, reactive oxygen species, advanced glycation end products, and oxidized low-density lipoprotein trigger the phosphorylation of IKKβ, which in turn phosphorylates IκBα for ubiquitination and degradation by proteasome [13–18].”
From Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes (2013) · cites this paper as [14]
Citations
Cites
Baeuerle, P. A., & Baltimore, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81318-5 · Cited by 3,002
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125
Self-citationDe-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O’Rourke, K. M., Zhou, H., Eby, M. T., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R. T., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,889
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
Self-citationIdentification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, T., Shirakabe, K., Shibuyà, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,344
Ninomiya‐Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,187
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z., & Leder, P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80535-x · Cited by 1,102
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,018
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 964
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 947
Cited by
Sorted by citations
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,954
Haas, T. L., Emmerich, C. H., Gerlach, B., Schmukle, A. C., Cordier, S. M., Rieser, E., Feltham, R., Vince, J. E., Warnken, U. H., Wenger, T., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.013 · Cited by 797
The Molecular Bases of Training Adaptation
Coffey, V. G., & Hawley, J. A. (2007) · Sports Medicine · doi:10.2165/00007256-200737090-00001 · Cited by 756
Perkins, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209937 · Cited by 674
Vallabhapurapu, S., Matsuzawa, A., Zhang, W., Tseng, P., Keats, J. J., Wang, H., Vignali, D. A. A., Bergsagel, P. L., & Karin, M. (2008) · Nature Immunology · doi:10.1038/ni.1678 · Cited by 605
Direct activation of protein kinases by unanchored polyubiquitin chains
Xia, Z.-P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., & Chen, Z. J. (2009) · Nature · doi:10.1038/nature08247 · Cited by 570
Self-citationUbiquitin-mediated activation of TAK1 and IKK
Adhikari, A., Xu, M., & Chen, Z. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210413 · Cited by 464
Self-citationNF-κB in inflammation and renal diseases
Zhang, H., & Sun, S.-C. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0056-4 · Cited by 383
Cell type-specific function of TAK1 in innate immune signaling
Alagbala, A. A., Wang, H. Y., & Wang, R. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.007 · Cited by 380
IκB kinase β (IKKβ/IKK2/IKBKB)—A key molecule in signaling to the transcription factor NF-κB
Schmid, J. A., & Birbach, A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.006 · Cited by 263
Role of nuclear factor κB in cardiovascular health and disease
der Heiden, K. V., Cuhlmann, S., Luong, L. A., Zakkar, M., & Evans, P. C. (2010) · Clinical Science · doi:10.1042/cs20090557 · Cited by 241
Wu, Z.-H., Wong, E. T., Shi, Y., Niu, J., Chen, Z. J., Miyamoto, S., & Tergaonkar, V. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.010 · Cited by 209
Self-citationFerch, U., Kloo, B., Gewies, A., Pfänder, V., Düwel, M., Peschel, C., Krappmann, D., & Ruland, J. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091167 · Cited by 202
Cell Signaling and Function Organized by PB1 Domain Interactions
Moscat, J., Díaz-Meco, M. T., Albert, A., & Campuzano, S. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.002 · Cited by 199
Roles of NF-κB in health and disease: mechanisms and therapeutic potential
Wong, E. T., & Tergaonkar, V. (2009) · Clinical Science · doi:10.1042/cs20080502 · Cited by 196
Angot, A., Vergunst, A. C., Genin, S., & Peeters, N. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030003 · Cited by 176
Coordinating TLR‐activated signaling pathways in cells of the immune system
Banerjee, A., & Gerondakis, S. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100098 · Cited by 163
TAK1-dependent Signaling Requires Functional Interaction with TAB2/TAB3
Besse, A., Lamothe, B., Campos, A. D., Webster, W. K., Maddineni, U., Lin, S., Wu, H., & Darnay, B. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608867200 · Cited by 147
Mukherjee, S., Hao, Y.-H., & Orth, K. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.03.007 · Cited by 141
Leulier, F., Lhocine, N., Lemaître, B., & Meier, P. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00548-06 · Cited by 136
Current concepts of IgE regulation and impact of genetic determinants
Potaczek, D. P., & Kabesch, M. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03953.x · Cited by 125
Alford, K. A., Glennie, S. J., Turrell, B. R., Rawlinson, L. M., Saklatvala, J., & Dean, J. L. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610987200 · Cited by 123
Phosphorylation and ubiquitination of the IκB kinase complex by two distinct signaling pathways
Shambharkar, P. B., Blonska, M., Pappu, B. P., Li, H., You, Y., Sakurai, H., Darnay, B. G., Hara, H., Penninger, J. M., & Lin, X. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601622 · Cited by 122
Fukushima, T., Matsuzawa, S., Kress, C. L., Bruey, J. M., Krajewska, M., Lefebvre, S., Zapata, J. M., Ronai, Z. A., & Reed, J. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700548104 · Cited by 114
Nighot, M., Rawat, M., Al–Sadi, R., Castillo, E. F., Nighot, P. K., & Ma, T. Y. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.12.016 · Cited by 111
Ku, C. S., Pham, T. X., Park, Y., Kim, B., Shin, M. S., Kang, I., & Lee, J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.018 · Cited by 109
An, S., Zhao, L., She, Z., Wang, S., Zhang, K., Yu, Q., Zheng, J., Zhang, X., Zhu, X., Bao, R., et al. (2017) · Hepatology · doi:10.1002/hep.29375 · Cited by 107
Omori, E., Morioka, S., Matsumoto, K., & Ninomiya‐Tsuji, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804513200 · Cited by 100
TAK1 Is a Central Mediator of NOD2 Signaling in Epidermal Cells
Kim, J., Omori, E., Matsumoto, K., Núñez, G., & Ninomiya‐Tsuji, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704746200 · Cited by 98
Sustained oxidative stress inhibits NF-κB activation partially via inactivating the proteasome
Wu, M., Bian, Q., Liu, Y., Fernandes, A. F., Taylor, A., Pereira, P., & Shang, F. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.021 · Cited by 99
Kim, S. I., Kwak, J. H., Na, H.-J., Kim, J. K., Ding, Y., & Choi, M. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007146 · Cited by 87
Srivastav, S., Kar, S., Chande, A. G., Mukhopadhyaya, R., & Das, P. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102845 · Cited by 85
Mao, R., Fan, Y., Mou, Y., Zhang, H., Fu, S., & Yang, J. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.09.006 · Cited by 73
Wu, X., & Sun, S. (2007) · EMBO Reports · doi:10.1038/sj.embor.7400931 · Cited by 72
Lou, H., & Kaplowitz, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706145200 · Cited by 71
Inagaki, M., Omori, E., Kim, J.-Y., Komatsu, Y., Scott, G., Ray, M. K., Yamada, G., Matsumoto, K., Mishina, Y., & Ninomiya-Tsuji, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807574200 · Cited by 68
HIV-1 Vpr stimulates NF-κB and AP-1 signaling by activating TAK1
Liu, R., Lin, Y., Jia, R., Geng, Y., Liang, C., Tan, J., & Qiao, W. (2014) · Retrovirology · doi:10.1186/1742-4690-11-45 · Cited by 66
Sánchez‐Duffhues, G., Calzado, M. A., de Vinuesa, A. G., Appendino, G., Fiebich, B. L., Loock, U., Lefarth‐Risse, A., Krohn, K., & Muñóz, E. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.01.004 · Cited by 65
Rosato, R. R., Kolla, S. S., Hock, S. K., Almenara, J. A., Patel, A. K., Amin, S., Atadja, P. W., Fisher, P. B., Dent, P., & Grant, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095208 · Cited by 64
RetractedSrivastava, A. K., Qin, X., Wedhas, N., Arnush, M., Linkhart, T. A., Chadwick, R. B., & Kumar, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705329200 · Cited by 63
Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition
Tareen, S. U., & Emerman, M. (2010) · Virology · doi:10.1016/j.virol.2010.09.018 · Cited by 63
Jin, W., Chang, M., & Sun, S. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2011.60 · Cited by 60
Shang, F., & Taylor, A. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.04.001 · Cited by 60
Essential role of TAK1 in regulating mantle cell lymphoma survival
Buglio, D., Palakurthi, S. S., Byth, K. F., Vega, F., Toader, D., Saeh, J. C., Neelapu, S. S., & Younes, A. (2012) · Blood · doi:10.1182/blood-2011-07-369397 · Cited by 59
The Lysosomal Transmembrane Protein 9B Regulates the Activity of Inflammatory Signaling Pathways
Dodeller, F., Gottar, M., Huesken, D., Iourgenko, V., & Cenni, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801908200 · Cited by 59
Omori, E., Inagaki, M., Mishina, Y. M., Matsumoto, K., & Ninomiya‐Tsuji, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116188109 · Cited by 55
TAB4 Stimulates TAK1-TAB1 Phosphorylation and Binds Polyubiquitin to Direct Signaling to NF-κB
Prickett, T. D., Ninomiya‐Tsuji, J., Broglie, P. M., Muratore‐Schroeder, T. L., Shabanowitz, J., Hunt, D. F., & Brautigan, D. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800943200 · Cited by 49
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy
Fan, Y., Cheng, J., Vasudevan, S. A., Patel, R. H., Li, L., Xu, X. Y., Zhao, Y., Jia, W., Lu, F., Zhang, H., et al. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0864-0 · Cited by 49
TAK1 kinase determines TRAIL sensitivity by modulating reactive oxygen species and cIAP
Morioka, S., Omori, E., Kajino, T., Kajino‐Sakamoto, R., Matsumoto, K., & Ninomiya‐Tsuji, J. (2009) · Oncogene · doi:10.1038/onc.2009.110 · Cited by 49
Comprehending the complex connection between PKCβ, TAK1, and IKK in BCR signaling
Shinohara, H., & Kurosaki, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00836.x · Cited by 49
Chen, K., Li, L., Li, C., Wang, Y., Yang, F., Kuang, M., & Wang, G. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3187972 · Cited by 47
NF-κB as a Target for Oncogenic Viruses
Sun, S., & Cesarman, E. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_108 · Cited by 46
TAK1 ubiquitination regulates doxorubicin-induced NF-κB activation
Liang, L., Fan, Y., Cheng, J., Cheng, D., Zhao, Y., Cao, B., Ma, L., An, L., Jia, W., Xu, S., et al. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.09.003 · Cited by 44
Wang, Z., Yang, Y., Yang, H., Capó‐Aponte, J. E., Tachado, S. D., Wolosin, J. M., & Reinach, P. S. (2011) · PubMed Central · Cited by 43
Japonicone A Suppresses Growth of Burkitt Lymphoma Cells through Its Effect on NF-κB
Li, X., Yang, X., Liu, Y., Gong, N., Yao, W., Chen, P., Qin, J., Jin, H., Li, J., Chu, R., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3258 · Cited by 42
DDX3 Participates in Translational Control of Inflammation Induced by Infections and Injuries
Ku, Y.-C., Lai, M.-H., Lo, C.-C., Cheng, Y., Qiu, J.-T. T., Tarn, W., & Lai, M. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00285-18 · Cited by 42
Pang, H.-Y., Liu, G., & Liu, G.-T. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2008.29 · Cited by 39
Effect of High-Frequency Resistance Exercise on Adaptive Responses in Skeletal Muscle
Coffey, V. G., Reeder, D. W., Lancaster, G. I., Yeo, W. K., Febbraio, M. A., Yaspelkis, B. B., & Hawley, J. A. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31815729b6 · Cited by 39
Roles of TRAF6 in CD40 signaling
Hostager, B. S. (2007) · Immunologic Research · doi:10.1007/s12026-007-0082-3 · Cited by 39
Wang, J.-S., Wu, D., Huang, D.-Y., & Lin, W. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0182-7 · Cited by 38
Romero, N., Waesberghe, C. V., & Favoreel, H. W. (2020) · Journal of Virology · doi:10.1128/jvi.00196-20 · Cited by 34
SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases
Wu, W., Wang, J., Xiao, C., Su, Z., Su, H., Zhong, W., Mao, J., Liu, X., & Zhu, Y. Z. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.591 · Cited by 33
IL-6 Induction by TNFα and IL-1β in an Osteoblast-Like Cell Line
Furia, A., Confalone, E., & D’Alessio, G. (2010) · International Journal of Biomedical Science · doi:10.59566/ijbs.2010.6135 · Cited by 33
Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-κB signaling
Jackson, S. S., Oberley, C. C., Hooper, C., Grindle, K. M., Wuerzberger‐Davis, S. M., Wolff, J., McCool, K. W., Rui, L., & Miyamoto, S. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.034 · Cited by 33
HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination
Li, T., Guan, J., Li, S.-Z., Zhang, X., & Zheng, X. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.197 · Cited by 32
Epithelial Cell Death and Inflammation in Skin
Kumari, S., & Pasparakis, M. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_466 · Cited by 33
Pan, M., Chang, H., Wu, Y., Huang, C.-C., & Hung, W.-C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806223200 · Cited by 31
Karagounis, L. G., Yaspelkis, B. B., Reeder, D. W., Lancaster, G. I., Hawley, J. A., & Coffey, V. G. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1427-5 · Cited by 31
POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway
Weng, T., & Koh, C.-G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.443 · Cited by 29
Bottero, V., Kerur, N., Sadagopan, S., Patel, K., Sharma-Walia, N., & Chandran, B. (2010) · Journal of Virology · doi:10.1128/jvi.01911-10 · Cited by 29
PGC‐1β suppresses saturated fatty acid‐induced macrophage inflammation by inhibiting TAK1 activation
Chen, H., Liu, Y., Li, D., Song, J., & Xia, M. (2016) · IUBMB Life · doi:10.1002/iub.1470 · Cited by 28
HTLV-1 Tax-mediated TAK1 activation involves TAB2 adapter protein
Yu, Q., Minoda, Y., Yoshida, R., Yoshida, H., Iha, H., Kobayashi, T., Yoshimura, A., & Takaesu, G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.172 · Cited by 28
Role of the Ubiquitin–Proteasome in Protein Quality Control and Signaling
Shang, F., & Taylor, A. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397863-9.00010-9 · Cited by 29
Resistance exercise and skeletal muscle: protein synthesis, degradation, and controversies
Ji, F., Lee, H. S., & Kim, J.-H. (2025) · European Journal of Applied Physiology · doi:10.1007/s00421-025-05832-z · Cited by 26
Activated Macrophage Survival Is Coordinated by TAK1 Binding Proteins
Mihaly, S. R., Morioka, S., Ninomiya‐Tsuji, J., & Takaesu, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094982 · Cited by 26
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis
Guan, S., Lu, J., Zhao, Y., Woodfield, S. E., Zhang, H., Xu, X. Y., Yu, Y., Zhao, J., Bieerkehazhi, S., Liang, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16895 · Cited by 25
Lluis, J. M., Nachbur, U., Cook, W. D., Gentle, I. E., Moujalled, D. M., Moulin, M., Wong, W. W.-L., Khan, N. R., Chau, D., Callus, B. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008620 · Cited by 24
Wu, Y., Starzinski‐Powitz, A., & Guo, S. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000279324 · Cited by 23
Zhang, Z., Yang, Z., Wang, S., Wang, X., & Mao, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117367 · Cited by 22
Zhang, J., Gao, F., & Xie, J. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.417 · Cited by 20
A20 Inhibits LPS-Induced Inflammation by Regulating TRAF6 Polyubiquitination in Rainbow Trout
Jang, J. H., Kim, H. J., Jung, I. Y., & Cho, J. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189801 · Cited by 19
Cianni, F. D., Campa, D., Tallaro, F., Rizzato, C., Rango, F. D., Barale, R., Passarino, G., Canzian, F., Gemignani, F., Montesanto, A., et al. (2012) · AGE · doi:10.1007/s11357-012-9416-8 · Cited by 18
Cuadrado, I., Cidre‐Aranaz, F., Herránz, S., Estévez‐Braun, A., Heras, B. D. L., & Hortelano, S. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.10.013 · Cited by 17
The Biology of A20-Like Molecules
Enesa, K., & Evans, P. C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0398-6_3 · Cited by 18
Poplutz, M. K., Levikova, M., Lüscher‐Firzlaff, J., Lesina, M., Algül, H., Lüscher, B., & Huber, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-04890-4 · Cited by 17
Wen, X., Qin, J., Zhang, X., Ye, L., Wang, Y., Yang, R., Di, Y., He, W., & Wang, Z. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216644 · Cited by 16
An F-box protein, FBXW5, negatively regulates TAK1 MAP3K in the IL-1β signaling pathway
Minoda, Y., Sakurai, H., Kobayashi, T., Yoshimura, A., & Takaesu, G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.052 · Cited by 16
Cho, Y.-C., Vuong, H. L., Ha, J., Lee, S., Park, J., Wibow, A. E., & Cho, S. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500548 · Cited by 15
Kim, S. H., Byun, J., Jung, S., Kim, B., Lee, K., Jeon, H., Lee, J., Choi, H. S., Kim, E. S., Jeen, Y., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10112693 · Cited by 15
Edwards, K. A., Motamedi, V., Osier, N. D., Kim, H., Yun, S., Cho, Y., Lai, C., Dell, K. C., Carr, W. S., Walker, P., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00091 · Cited by 15
Takaesu, G., Inagaki, M., Takubo, K., Mishina, Y. M., Hess, P. R., Dean, G. A., Yoshimura, A., Matsumoto, K., Suda, T., & Ninomiya‐Tsuji, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051073 · Cited by 14
TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma
Campolo, M., Lanza, M., Casili, G., Paterniti, I., Filippone, A., Caffo, M., Cardali, S. M., Puliafito, I., Colarossi, C., Raciti, G., et al. (2020) · Cancers · doi:10.3390/cancers13010041 · Cited by 14
Liao, C., Zhou, H., Chen, H., Guo, C., Li, S., Ma, F., Yang, X., Xie, B., & Zhang, W. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109284 · Cited by 13
Chiou, W., Chen, C., Lin, I.-H., Chiu, J., & Chen, Y. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.022 · Cited by 12
Yang, X. Y., Ai, Y., Chen, L., Wang, C., Liu, J., Zhang, J., Li, J., Wu, H. M., Xiao, J., Chang, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.999219 · Cited by 12
Partners in crime: POPX2 phosphatase and its interacting proteins in cancer
Kim, P. R., Zhang, S., Rahmat, M. B. B., & Koh, C.-G. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03061-0 · Cited by 10
Joo, E., Fukushima, T., Harada, N., Reed, J. C., Matsuzawa, S.-I., & Inagaki, N. (2016) · Scientific Reports · doi:10.1038/srep35983 · Cited by 9
USP13 ameliorates nonalcoholic fatty liver disease through inhibiting the activation of TAK1
Tang, M. M., Cao, H., Ma, Y., Yao, S., Wei, X., Tan, Y., liu, F., Peng, Y., & Fan, N. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05465-4 · Cited by 8
The Emerging Role of OTUB2 in Diseases: From Cell Signaling Pathway to Physiological Function
Li, J., Zhang, N., Li, M., Hong, T., Meng, W., & Ouyang, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.820781 · Cited by 7
Zhang, J., Li, B., Wu, H., Ou, J., Wei, R., Liu, J., Cai, W., Liu, X., Zhao, S., Yang, J., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-3832-1 · Cited by 7
Metadata
- Authors
- Chen, Z. J., Bhoj, V, & Seth, R. B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Chen, Z J
- ORCID
- Bhoj, V
- Venue
- Cell Death & Differentiation
- Published
- 2006-02-17
- Volume
- 13
- Issue
- 5
- Pages
- 687-692
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W1992744008
- Cited by
- 115
- References
- 21
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 2 · 2015: 5 · 2014: 5 · 2013: 4 · 2012: 10
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM063692, R01 GM63692)
- National Institute of Allergy and Infectious Diseases (R01-AI 60919, R01AI060919)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NF-κB signaling, TAK1, IKK activation, ubiquitination, TRAF6, E3 ubiquitin ligase, polyubiquitin chains, IκB kinase, TNF signaling, IL-1β signaling
- MeSH terms
- MAP Kinase Kinase Kinase 7, Animals, Enzyme Activation, Gene Expression Regulation, Immunity, Active, Immunity, Innate, Interleukin-1, Models, Biological, Tumor Necrosis Factor-alpha, Signal Transduction, MAP Kinase Kinase Kinases, Ubiquitin, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review